As of September 10, 2026, Emerson Electric Co. (EMR) trades at $148.37. CleaRank Financial AI rates it Buy with a fair value of $175.00, 17.9% above the current price. Wall Street's consensus target is $175.00 across 29 analysts. RSI at 38 is in neutral territory, and the price is below its 50-day average of $149.75.
Emerson Electric Co. (EMR)
Emerson Electric Co. NYSE
EMR Price Analysis
Market Metrics
Peer Benchmarking
Valuation vs Sector (Industrials)
Performance vs XLI
Sector Position Analysis
EMR Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
EMR Analysis
- Monitor insider transactions closely; while recent activity shows moderate selling, any shift towards net buying could signal renewed institutional confidence.
- The stock is trading below its 50-day SMA ($149.75) but above its 200-day SMA ($142.95), indicating underlying strength, but the bearish RSI momentum warrants caution for short-term entry.
- Given the premium valuation, consider dollar-cost averaging into positions to mitigate entry risk and benefit from potential price dips.
Emerson Electric has a strong track record of meeting or exceeding EPS estimates, most recently beating by 1.79% in August 2026, which supports its current 'Buy' consensus rating.
Source: Earnings ReportsA median analyst price target of $175.00 from 29 analysts suggests a potential 16.4% upside from the current price, reinforcing a bullish outlook.
Source: Wall Street AnalystsRecent insider transactions show $13.1 million in sales with no reported purchases, indicating a moderate sell signal that warrants investor attention.
Source: Insider TransactionsThe RSI is below 40 and the MACD is negative, suggesting bearish momentum in the short term, which could lead to price pullbacks.
Source: Technical AnalysisKey Statistics
| Market Cap | 83.86B |
|---|---|
| P/E Ratio | 33.52 |
| EPS (TTM) | 4.57 |
| Dividend Yield | 1.48% |
| 52 Week High | 166.35 |
| 52 Week Low | 122.64 |
Earnings & Growth Analysis
Key Risks
Technical Indicators
| RSI (14) | 37.90 |
|---|---|
| MACD | -0.49 |
| SMA 50 | 149.75 |
| SMA 200 | 142.95 |
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
EMR Trade Plans
Specific entry, exit, and risk management levels
🟢 LONG ENTRY (click to switch)
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
A $10,000 investment in EMR in September 2016 would be worth about $28,862 today, compared with about $35,241 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in EMR today could grow to about $24,086 by 2036 in the base case, with a bull case near $79,310 and a bear case around $7,315. Projections are statistical simulations, not guarantees.
EMR Stock Price Prediction: 2030
CleaRank's simulation projects a price near $211 for EMR by 2030 in the base case, from $148 today (1.4x over 4 years). The downside path ends near $99.25. These are outcomes of a Monte Carlo simulation run on EMR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $111 | $162 | $236 |
| 2028 | $104 | $177 | $301 |
| 2029 | $101 | $193 | $371 |
| 2030 | $99.25 | $211 | $448 |
| 2031 | $99.14 | $230 | $535 |
| 2032 | $99.88 | $251 | $633 |
| 2033 | $101 | $275 | $744 |
| 2034 | $103 | $300 | $870 |
| 2035 | $106 | $327 | $1,014 |
| 2036 | $109 | $357 | $1,177 |
Method: 10,000 simulated price paths using EMR's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
EMR Insider Trading Analysis
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 8, 2022 | DELLAQUILA FRANK J
Chief Financial Officer
|
Sell | 87.7K | $8.0M |
| Nov 13, 2024 | KARSANBHAI SURENDRALAL LANCA
Chief Executive Officer
|
Sell | 52.4K | $6.8M |
| Sep 10, 2018 | MONSER EDWARD L
President
|
Sell | 60.0K | $4.6M |
| Jun 27, 2023 | FLAVIN LISA A.
Officer
|
Sell | 48.7K | $4.4M |
| Aug 14, 2018 | DELLAQUILA FRANK J
Chief Financial Officer
|
Sell | 47.5K | $3.5M |
| May 12, 2025 | TRAIN MICHAEL H
Officer
|
Sell | 28.3K | $3.4M |
| Nov 12, 2019 | DELLAQUILA FRANK J
Chief Financial Officer
|
Sell | 42.8K | $3.2M |
| Nov 6, 2024 | TRAIN MICHAEL H
Officer
|
Sell | 21.5K | $2.7M |
| May 8, 2025 | KARSANBHAI SURENDRALAL LANCA
Chief Executive Officer
|
Sell | 16.7K | $1.9M |
| Jun 18, 2018 | TRAIN MICHAEL H
Officer
|
Sell | 24.2K | $1.7M |
